Sanofi

Pursue Progress. Discover Extraordinary.

Science has been our calling from the beginning. Sanofi’s heritage of turning the impossible into the possible stretches back to the 19th century — a rich history of healthcare innovation built by diverse companies united by one shared purpose. More than 150 years later, that spirit lives in everything we do and every person we serve — from the patients who take our medicines, to the healthcare professionals who trust us, to the 83,000+ employees and communities around the world who make it all possible. And today, we’re writing the next chapter of that legacy.

We are an R&D-driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth.

Better is out there. Better medications, better outcomes, better science. And it all starts with people like you — from different backgrounds, in different locations, doing different roles — united by a single mission: we chase the miracles of science to improve people’s lives.

Take the most important step in your career and help us change the lives of patients, families, and communities for the better.

Explore Open Roles →

  • Featured Employer
What could we achieve together? Sign up today and discover our latest opportunities as soon as they’re available.
Reinvention is in our DNA. It’s what drove our evolution from a small French enterprise to one of the world’s leading biopharma companies — present in 70+ countries and growing. Whether it’s harnessing AI to shorten drug-discovery timelines, pioneering transformative treatments, or building trust in healthcare systems worldwide, you could be helping our teams make life better for patients, partners, and communities.

This is where you grow your career. We open the door for you to explore new roles, take on stretch assignments, and connect with people driven by a shared purpose. Our culture of high performance and belonging is grounded in four core values:: Aim Higher, Act for Patients, Be Bold, and Lead Together.

At Sanofi, we believe every person can lead from where they are. You’ll learn to grow your skills and evolve as a leader through our Leadership Frame. Connect with mentors via our Career Hub, and explore new possibilities through “gigs”, where you’ll work on short-term projects to try something new on another team. You’ll do it all with our full support, increasing your exposure to business leaders, and expanding your network across the industry.
All Well, together. We support healthy bodies, healthy minds, healthy financials, and a healthy working culture for all Sanofians. Our dedication to improving people’s lives starts at home, with the health and wellbeing of our employees and their families.
We want you to share your voice and challenge us, even when it might feel uncomfortable. We’ll help turn your ideas into action, based on tangible measures. Because it’s action, not intent, that makes change sustainable and gives us our Diversity Edge.

We’re the first in pharma to have a Diversity, Equity and Inclusion (DE&I) Board with external members. And every member of our Executive Committee is represented either on the DE&I board or as a sponsor of a global Employee Resource Group (ERG). Diversity is our strength. Boldly, proudly and unapologetically. We’re All In on DE&I. Come and be part of it.
What is the Sanofi Feeling?

You are unique. How you feel on any given day is unique. Who you are with, and the environment you’re in, has the power to shape and enhance how you feel. At Sanofi, it’s not just about the chair you sit in. We’ve blended art with science and looked at every detail to match your uniqueness.

We’re transforming healthcare and improving lives through our work, our people, and our stories. You’ll get a glimpse of what life here is like, you’ll hear inspiring stories and you’ll dive into the projects that reveal the miracles of science. Let’s live extraordinarily.
AWARDS
  • Sanofi Human Rights Campaign award.png
  • Sanofi award_usa-2.png
  • Sanofi award_usa-3.png
  • 2023 Best Places to Work
  • 2022 Best Places to Work
NEWS
Many companies have foreshadowed deals to come during earnings calls in recent days. The return of M&A would be a welcome sign for the biopharma ecosystem, which has been battered by macro headwinds such as tariffs and the possibility of new drug pricing pressures.
Dupixent, which was rejected by the FDA for chronic spontaneous urticaria in October 2023, is now approved as the first new targeted therapy for the indication in more than 10 years.
The French pharma giant has made multiple trips to the artificial intelligence well over the past few years, this time with Delaware-based Earendial Labs.
Analysts at Leerink agreed with Sanofi that, despite falling short of statistical significance in the Phase II TIDE-Asthma trial, amlitelimab warrants further development in this indication.
FDA
Lined up for the FDA in the coming weeks are a cell-based gene therapy for a rare skin disease and two product expansions for Regeneron, one with partner Sanofi.
Unlike other hemophilia therapies, Qfitlia is indicated for both hemophilia A and B, and can be given in patients regardless of the presence of neutralizing antibodies against clotting factor VIII or IX.
I&I
The deal is the latest in a series of Sanofi investments in its immunology portfolio. According to Sanfoi, DR-0201 can achieve deep B cell depletion, giving it the potential to reset the immune system.
On the agenda for the FDA this month are two RNA-based treatments for rare diseases.
The last few years have been tough for the insulin market, with recent policies and high-level pressure forcing companies to lower drug prices.
JOBS
IN THE PRESS